Farshid Mohsenzadeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Farshid Mohsenzadeh has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Kioumars Aghapoor
Applied Chemicals Synthesis Lab., Chemistry & Chemical Engineering Research Center of Iran, Tehran, Iran
36 shared publications Hossein Reza Darabi
16 shared publications- Hossein Reza Darabi
Nano & Organic Synthesis Lab, Chemistry & Chemical Engineering Research Center of Iran, Tehran, Iran
16 shared publications - Hani Sayahi
Chemistry and Chemical Engineering Research Center of Iran
8 shared publications Yadollah Balavar
Chemistry and Chemical Engineering Research Center of Iran
8 shared publications- Mitra Ghassemzadeh
Chemistry and Chemical Engineering Research Center of Iran
7 shared publications
Latest Publications
- 9 March 2023
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 37 (5)
Imidazolium organometallic complex of palladium on Fe3O4 nanoparticles as selective and magnetically recoverable nanocatalyst for C‐C cross‐coupling reactions
The synthesis of an efficient heterogeneous nanocatalyst was prepared by the anchoring of palladium complex on the surface of an imidazolium‐based ionic liquid‐functionalized Fe3O4 (Pd‐imidazolium@Fe3O4 NPs). The nanocatalyst, Pd‐imidazolium@Fe3O4 NPs, was characterized by Raman, X‐ray diffraction (XRD), thermogravimetric analysis (TGA), transmission electron microscopy (TEM), scanning electron microscopy (SEM), energy‐dispersive X‐ray spectroscopy (EDX), fourier transform infrared (FT‐IR), inductively coupled plasma (ICP), and vibrating sample magnetometer (VSM) techniques. The catalytic performance of this novel nanocatalyst was evaluated in the Heck––Mizoroki and Suzuki–Miyaura cross‐coupling reactions under mild conditions using PEG‐400 as a green and biodegradable solvent. The nanocatalyst exhibited high catalytic activity for both cross‐coupling reactions. Furthermore, this stable nanocatalyst can be easily removed and recovered from the reaction mixture and reused for at least eight consecutive cycles without a discernible decrease in the catalytic activity. Also, the recovered Pd‐imidazolium@Fe3O4 NPs was characterized by FT‐IR, XRD, scanning electron microscopy, energy‐dispersive X‐ray spectroscopy, and atomic absorption spectroscopy techniques.
- 9 March 2023
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 37 (5)
Imidazolium organometallic complex of palladium on Fe3O4 nanoparticles as selective and magnetically recoverable nanocatalyst for C‐C cross‐coupling reactions
The synthesis of an efficient heterogeneous nanocatalyst was prepared by the anchoring of palladium complex on the surface of an imidazolium‐based ionic liquid‐functionalized Fe3O4 (Pd‐imidazolium@Fe3O4 NPs). The nanocatalyst, Pd‐imidazolium@Fe3O4 NPs, was characterized by Raman, X‐ray diffraction (XRD), thermogravimetric analysis (TGA), transmission electron microscopy (TEM), scanning electron microscopy (SEM), energy‐dispersive X‐ray spectroscopy (EDX), fourier transform infrared (FT‐IR), inductively coupled plasma (ICP), and vibrating sample magnetometer (VSM) techniques. The catalytic performance of this novel nanocatalyst was evaluated in the Heck––Mizoroki and Suzuki–Miyaura cross‐coupling reactions under mild conditions using PEG‐400 as a green and biodegradable solvent. The nanocatalyst exhibited high catalytic activity for both cross‐coupling reactions. Furthermore, this stable nanocatalyst can be easily removed and recovered from the reaction mixture and reused for at least eight consecutive cycles without a discernible decrease in the catalytic activity. Also, the recovered Pd‐imidazolium@Fe3O4 NPs was characterized by FT‐IR, XRD, scanning electron microscopy, energy‐dispersive X‐ray spectroscopy, and atomic absorption spectroscopy techniques.
- 26 January 2022
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 46 (6) , 3026-3034
In vitrocytotoxicity and antibacterial activity of [Pd(AMTTO)(PPh3)2]: a novel promising palladium(ii) complex
The synthesis of a new palladium(II) complex, [Pd(AMTTO)(PPh3)2] (1, H2AMTTO = 4-amino-6-methyl-1,2,4-triazine-3-thione-5-one), is reported. Complex 1 has been characterized by FT-IR, 1H NMR and 31P NMR spectroscopy as well as mass spectrometry. Furthermore, its molecular structure and thermal stability have been investigated via X-ray and thermogravimetric analyses. The crystal structure of 1 revealed that the twofold deprotonated ligand acts as a bidentate chelating one and coordinates to the metal ion through its sulfur and nitrogen atoms in a cis-arrangement. The biological activity including anticancer and antibacterial activity of the ligands and complex 1 was studied. The IC50 value of the latter against MCF-7 was 0.06 mM. This is while carboplatin (as a standard anticancer drug) exhibited no cytotoxicity at the same concentration. Moreover, the synthesized Pd(II) complex displayed potent antimicrobial activity against Gram-positive (ATCC 6538) and Gram-negative (ATCC 25922) bacterial strains.
- 26 January 2022
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 46 (6) , 3026-3034
In vitrocytotoxicity and antibacterial activity of [Pd(AMTTO)(PPh3)2]: a novel promising palladium(ii) complex
The synthesis of a new palladium(II) complex, [Pd(AMTTO)(PPh3)2] (1, H2AMTTO = 4-amino-6-methyl-1,2,4-triazine-3-thione-5-one), is reported. Complex 1 has been characterized by FT-IR, 1H NMR and 31P NMR spectroscopy as well as mass spectrometry. Furthermore, its molecular structure and thermal stability have been investigated via X-ray and thermogravimetric analyses. The crystal structure of 1 revealed that the twofold deprotonated ligand acts as a bidentate chelating one and coordinates to the metal ion through its sulfur and nitrogen atoms in a cis-arrangement. The biological activity including anticancer and antibacterial activity of the ligands and complex 1 was studied. The IC50 value of the latter against MCF-7 was 0.06 mM. This is while carboplatin (as a standard anticancer drug) exhibited no cytotoxicity at the same concentration. Moreover, the synthesized Pd(II) complex displayed potent antimicrobial activity against Gram-positive (ATCC 6538) and Gram-negative (ATCC 25922) bacterial strains.